Nurse-led risk assessment/management clinics reduce predicted cardiac morbidity and mortality in claudicants

Journal of Vascular Nursing

Volumn 26, Issue 4, 2008, Pages 118-122

  Hatfield, Josephine ^a   Gulati, Sumit ^a   Abdul Rahman, Morhisham N A ^a   Coughlin, Patrick A ^a   Chetter, Ian C ^a  

^a HULL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CORONARY ARTERY DISEASE; EXERCISE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTERMITTENT CLAUDICATION; MALE; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE ATTITUDE; NURSING; PATIENT COMPLIANCE; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION;

AGED; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; HYPERTENSION; INTERMITTENT CLAUDICATION; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NURSE'S ROLE; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING CESSATION;

EID: 55949095262     PISSN: 10620303     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvn.2008.09.004     Document Type: Article

References (25)

1. Fowkes F.G., Housley E., Cawood E.H., Macintyre C.C., Ruckley C.V., and Prescott R.J. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20 (1991) 384-392
2. Dormandy J., Heeck L., and Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg 12 (1999) 123-137
3. Wood D., Durrington P., Poulter N., McInnes G., Rees A., and Wray R. Joint British Recommendations on prevention of coronary heart disease in clinical practice. Heart 80 Suppl. 2 (1998) S1-S29
4. Richardson G., van Woerden H.C., Morgan L., Edwards R., Harries M., Hancock E., Sroczynsk S., and Bowley M. Healthy hearts - a community based primary prevention programme to reduce coronary heart disease. BMC Cardiovascular Disorders 8 (2008) 8-18
5. D'Agostino Sr. R.B., Grundy S., Sullivan L.M., and Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286 (2001) 180-187
6. Assmann G., Cullen P., and Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 105 (2002) 310-331
7. McDermott M.M., Mehta S., Ahn H., and Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 12 (1997) 209-215
8. Cassar K., Belch J.J., and Brittenden J. Are national cardiac guidelines being applied by vascular surgeons?. Eur J Vasc Endovasc Surg 26 (2003) 623-628
9. Cassar K., Coull R., Bachoo P., Macaulay E., and Brittenden J. Management of secondary risk factors in patients with intermittent claudication. Eur J Vasc Endovasc Surg 26 (2003) 262-266
10. Sol B.G., van der Bijl J.J., Banga J.D., and Visseren F.L. Vascular risk management through nurse-led self-management programs. J Vasc Nurs 23 (2005) 20-24
11. Middleton E.T., and Morice A.H. Breath carbon monoxide as an indication of smoking habit. Chest 117 (2000) 758-763
12. Morgan M.B., Crayford T., Murrin B., and Fraser S.C. Developing the Vascular Quality of Life Questionnaire: a new disease-specific quality of life measure for use in lower limb ischemia. J Vasc Surg 33 (2001) 679-687
13. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
14. Raw M., McNeill A., and West R. Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Health Education Authority. Thorax 53 Suppl 5 (1998) S1-S19
15. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives. JAMA 283 (2000) 3244-3254
16. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
17. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308 (1994) 81-106
18. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
19. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352 (1998) 837-853
20. Tierney S., Fennessy F., and Hayes D.B. ABC of arterial and vascular disease. Secondary prevention of peripheral vascular disease. BMJ 320 (2000) 1262-1265
21. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 (2000) 145-153
22. Haq I.U., Ramsay L.E., Yeo W.W., Jackson P.R., and Wallis E.J. Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men. Heart 81 (1999) 40-46
23. Cooper J.A., Miller G.J., and Humphries S.E. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis 181 (2005) 93-100
24. Coughlin P.A., Gulati V., Mavor A.I., Gough M.J., and Homer-Vanniasinkam S. Risk factor awareness in patients with peripheral arterial disease. J Cardiovasc Surg (Torino) 48 (2007) 735-740
25. Willigendael E.M., Teijink J.A., Bartelink M.L., Boiten J., Moll F.L., Büller H.R., and Prins M.H. Peripheral arterial disease: public and patient awareness in The Netherlands. Eur J Vasc Endovasc Surg 27 (2004) 622-628